BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23937231)

  • 1. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
    Ganjiwale A; Cowsik SM
    Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A; Capriati A; Altamura M; Maggi CA
    Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
    Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
    Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinins and tachykinin receptors: structure and activity relationships.
    Almeida TA; Rojo J; Nieto PM; Pinto FM; Hernandez M; Martín JD; Candenas ML
    Curr Med Chem; 2004 Aug; 11(15):2045-81. PubMed ID: 15279567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinins: receptor to effector.
    Khawaja AM; Rogers DF
    Int J Biochem Cell Biol; 1996 Jul; 28(7):721-38. PubMed ID: 8925404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
    Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
    Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship.
    Severini C; Salvadori S; Guerrini R; Falconieri-Erspamer G; Mignogna G; Erspamer V
    Peptides; 2000 Nov; 21(11):1587-95. PubMed ID: 11090912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinins in the gut. Part I. Expression, release and motor function.
    Holzer P; Holzer-Petsche U
    Pharmacol Ther; 1997; 73(3):173-217. PubMed ID: 9175155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
    Goldhill J; Angel I
    Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
    Lavagno L; Bordin G; Colangelo D; Viano I; Brunelleschi S
    Neuropeptides; 2001 Apr; 35(2):92-9. PubMed ID: 11384204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin receptors mediating contractions of oestrogen-primed rat uterus: classification using non-peptide antagonists.
    Fisher L; Pennefather JN
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):729-35. PubMed ID: 10499163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore and receptor models for neurokinin receptors.
    Poulsen A; Bjørnholm B; Gundertofte K; Pogozheva ID; Liljefors T
    J Comput Aided Mol Des; 2003 Nov; 17(11):765-83. PubMed ID: 15072436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
    Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
    J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.